Effect of biotin, brewer’s yeast and vitamin C supplements in patients with COVID-19
Phase 3
Recruiting
- Conditions
- Coronavirus disease 2019 (COVID-19).U07. 1
- Registration Number
- IRCT20201004048923N1
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Male
- Target Recruitment
- 50
Inclusion Criteria
Age between 20 to 60 years old
Male sex
COVID-19 patients with positive chest CT scan
Exclusion Criteria
Infectious diseases, cancer and autoimmune diseases
Severe heart and liver diseases
Existence of severe clinical symptoms that require hospitalization
Diabetes
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical symptoms improvement. Timepoint: At the beginning of the study (before the intervention) and after receiving supplements, daily. Method of measurement: Patient statements during the phone call and recording information according to the scoring system designed in the checklist.
- Secondary Outcome Measures
Name Time Method